Bridging the divide: unveiling mutual immunological pathways of cancer and pregnancy
Inflammation Research · 2024
DOI: 10.1007/s00011-024-01866-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammation Research, 2024. Verfasst von Teodora Maria Toadere und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400006, Cluj-Napoca, Romania. toadere.teodora.maria@elearn.umfcluj.r…. Hauptthemen laut MEDLINE: Pregnancy, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 174 Literaturangaben.
Abstract (Originalsprache)
The juxtaposition of two seemingly disparate physiological phenomena within the human body-namely, cancer and pregnancy-may offer profound insights into the intricate interplay between malignancies and the immune system. Recent investigations have unveiled striking similarities between the pivotal processes underpinning fetal implantation and successful gestation and those governing tumor initiation and progression. Notably, a confluence of features has emerged, underscoring parallels between the microenvironment of tumors and the maternal-fetal interface. These shared attributes encompass establishing vascular networks, cellular mobilization, recruitment of auxiliary tissue components to facilitate continued growth, and, most significantly, the orchestration of immune-suppressive mechanisms.Our particular focus herein centers on the phenomenon of immune suppression and its protective utility in both of these contexts. In the context of pregnancy, immune suppression assumes a paramount role in shielding the semi-allogeneic fetus from the potentially hostile immune responses of the maternal host. In stark contrast, in the milieu of cancer, this very same immunological suppression fosters the transformation of the tumor microenvironment into a sanctuary personalized for the neoplastic cells.Thus, the striking parallels between the immunosuppressive strategies deployed during pregnancy and those co-opted by malignancies offer a tantalizing reservoir of insights. These insights promise to inform novel avenues in the realm of cancer immunotherapy. By harnessing our understanding of the immunological events that detrimentally impact fetal development, a knowledge grounded in the context of conditions such as preeclampsia or miscarriage, we may uncover innovative immunotherapeutic strategies to combat cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400006, Cluj-Napoca, Romania. toadere.teodora.maria@elearn.umfcluj.ro.
- Department of Physiology, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400006, Cluj-Napoca, Romania. tichindeleanu.andra@elearn.umfcluj.ro.
- Department of Physiology, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400006, Cluj-Napoca, Romania.
Zitieren
APA
Toadere, T. M., Ţichindeleanu, A., Bondor, D. A., Topor, I., Trella, Ş. E., & Nenu, I. (2024). Bridging the divide: unveiling mutual immunological pathways of cancer and pregnancy. Inflammation Research. https://doi.org/10.1007/s00011-024-01866-9
Vancouver
Toadere TM, Ţichindeleanu A, Bondor DA, Topor I, Trella ŞE, Nenu I. Bridging the divide: unveiling mutual immunological pathways of cancer and pregnancy. Inflammation Research. 2024. doi:10.1007/s00011-024-01866-9
BibTeX
@article{Toadere2024,
author = {Toadere, Teodora Maria and Ţichindeleanu, Andra and Bondor, Daniela Andreea and Topor, Ioan and Trella, Şerban Ellias and Nenu, Iuliana},
title = {Bridging the divide: unveiling mutual immunological pathways of cancer and pregnancy},
journal = {Inflammation Research},
year = {2024},
doi = {10.1007/s00011-024-01866-9}
}
EUVIMED